---
$id: https://graph.org.ai/products/commodity/51111753
$type: Product
source: UNSPSC
code: "51111753"
title: "Mitoguazone"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mitoguazone

**UNSPSC Code**: 51111753
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a s-adenosyl-methionine decarboxylase inhibitor and polyamine inhibitory agent with the molecular formula C5H12N8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OD5Q0L447W, chemically known as 1,1-((methylethanediylidene)dinitrilo)diguanidine but generally known as mitoguazone, which bears US NIH Compound Identifier 5351154. European Medicines Agency schedules Mitoguazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09004MIG. The term MITOGUAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules mitoguazone in its Anatomical Therapeutic Chemical (ATC) Classification. MITOGUAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mitoguazone under HS 29252900 and SITC 51482. As of Q4 2014, MITOGUAZONE remains the US FDA Preferred Term for this commodity. Mitoguazone bears US NLM identifiers UMLS ID C0026251 and NCI Concept Code C661. SMILES: N(=C(\C)/C=N/N=C(/N)N)\N=C(\N)N.

